Financial results - SPHYNX MEDICINE S.R.L.

Financial Summary - Sphynx Medicine S.r.l.
Unique identification code: 38628593
Registration number: J29/2874/2017
Nace: 8622
Sales - Ron
68.834
Net Profit - Ron
46.506
Employees
1
Open Account
Company Sphynx Medicine S.r.l. with Fiscal Code 38628593 recorded a turnover of 2024 of 68.834, with a net profit of 46.506 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Sphynx Medicine S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 0 2.740 3.731 5.361 6.227 4.022 34.220 68.834
Total Income - EUR - - 0 2.740 3.731 5.361 6.227 4.022 34.220 68.834
Total Expenses - EUR - - 0 4.334 3.899 7.241 7.705 15.807 22.199 14.204
Gross Profit/Loss - EUR - - 0 -1.594 -168 -1.879 -1.478 -11.785 12.021 54.630
Net Profit/Loss - EUR - - 0 -1.676 -280 -2.040 -1.665 -11.906 12.021 46.506
Employees - - 0 0 0 0 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 102.3%, from 34.220 euro in the year 2023, to 68.834 euro in 2024. The Net Profit increased by 34.552 euro, from 12.021 euro in 2023, to 46.506 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Sphynx Medicine S.r.l.

Rating financiar

Financial Rating -
SPHYNX MEDICINE S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Sphynx Medicine S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Sphynx Medicine S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Sphynx Medicine S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Sphynx Medicine S.r.l. - CUI 38628593

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 27 0 474 20.137 14.418 9.762 4.452 17
Current Assets - - 127 1.355 21.928 997 5.741 5.995 15.144 32.884
Inventories - - 0 0 0 0 453 3.800 4.358 0
Receivables - - 0 231 21.838 0 0 1.418 824 13.324
Cash - - 127 1.124 90 997 5.288 776 9.962 19.560
Shareholders Funds - - 44 -1.633 -1.881 -3.879 -5.458 -17.381 -5.294 30.142
Social Capital - - 44 43 42 48 46 47 59 58
Debts - - 109 3.082 24.511 25.303 25.690 33.210 25.127 2.759
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 32.884 euro in 2024 which includes Inventories of 0 euro, Receivables of 13.324 euro and cash availability of 19.560 euro.
The company's Equity was valued at 30.142 euro, while total Liabilities amounted to 2.759 euro. Equity increased by 35.407 euro, from -5.294 euro in 2023, to 30.142 in 2024.

Risk Reports Prices

Reviews - Sphynx Medicine S.r.l.

Comments - Sphynx Medicine S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.